维替泊芬光动力疗法治疗高度近视性黄斑中心凹下脉络膜新生血管
Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.
作者信息
Montero J A, Ruiz-Moreno J M
机构信息
Instituto Oftalmológico de Alicante, Vitreo-Retinal Unit, Spain.
出版信息
Br J Ophthalmol. 2003 Feb;87(2):173-6. doi: 10.1136/bjo.87.2.173.
Abstract
AIMS
To analyse the visual and angiographic results of photodynamic therapy (PDT) with verteporfin in highly myopic patients with subfoveal choroidal neovascularisation (CNV).
METHODS
PDT was performed on highly myopic patients with subfoveal CNV. The patient population was divided into two groups according to age at onset of CNV (group 1 aged < or = 55 and group 2 aged >55 years old). Best corrected visual acuity (BCVA) and angiographic findings were considered.
RESULTS
At the end of follow up group 2 had worse BCVA than group 1. 76% of patients in both groups showed a complete closure of CNV at the end of follow up.
CONCLUSION
Visual prognosis of myopic CNV treated by PDT is influenced by age at onset.
摘要
目的
分析维替泊芬光动力疗法（PDT）治疗高度近视性黄斑下脉络膜新生血管（CNV）患者的视力及血管造影结果。
方法
对高度近视性黄斑下CNV患者进行PDT治疗。根据CNV发病年龄将患者人群分为两组（1组年龄≤55岁，2组年龄＞55岁）。评估最佳矫正视力（BCVA）及血管造影结果。
结果
随访结束时，2组的BCVA比1组差。两组中76%的患者在随访结束时CNV完全闭合。
结论
PDT治疗近视性CNV的视力预后受发病年龄影响。
相似文献
1
Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.维替泊芬光动力疗法治疗高度近视性黄斑中心凹下脉络膜新生血管
Br J Ophthalmol. 2003 Feb;87(2):173-6. doi: 10.1136/bjo.87.2.173.
2
Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes.高度近视眼中黄斑中心凹下脉络膜新生血管光动力治疗后的视网膜下纤维化
Br J Ophthalmol. 2003 Jul;87(7):856-9. doi: 10.1136/bjo.87.7.856.
3
Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.年龄相关性黄斑变性和病理性近视脉络膜新生血管光动力治疗后的血管造影特征
Br J Ophthalmol. 2003 Feb;87(2):177-83. doi: 10.1136/bjo.87.2.177.
4
Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.维替泊芬光动力疗法治疗中国患者病理性近视性黄斑下脉络膜新生血管：一项为期1年和2年随访的前瞻性研究。
Br J Ophthalmol. 2004 Oct;88(10):1315-9. doi: 10.1136/bjo.2004.041624.
5
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.病理性近视性黄斑下脉络膜新生血管的维替泊芬治疗：一项随机临床试验的2年结果——VIP报告第3号
Ophthalmology. 2003 Apr;110(4):667-73. doi: 10.1016/s0161-6420(02)01998-x.
6
Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.临床环境中高度近视性黄斑下脉络膜新生血管的光动力疗法：治疗时年龄与视力预后的关系
Am J Ophthalmol. 2004 Oct;138(4):602-7. doi: 10.1016/j.ajo.2004.05.074.
7
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.维替泊芬光动力疗法治疗病理性近视性黄斑下脉络膜新生血管。一项随机临床试验的1年结果——VIP报告第1号
Ophthalmology. 2001 May;108(5):841-52. doi: 10.1016/s0161-6420(01)00544-9.
8
Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre.光动力疗法、雷珠单抗/贝伐单抗或联合治疗近视性脉络膜新生血管的比较：来自单一中心的9年研究。
Br J Ophthalmol. 2016 Oct;100(10):1337-40. doi: 10.1136/bjophthalmol-2015-307802. Epub 2016 Jan 20.
9
Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes.光动力疗法治疗近视眼中的黄斑旁脉络膜新生血管
Am J Ophthalmol. 2003 Aug;136(2):371-4. doi: 10.1016/s0002-9394(03)00201-0.
10
Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.维替泊芬光动力疗法治疗病理性近视性黄斑下脉络膜新生血管：一项12个月的回顾性研究
Eur J Ophthalmol. 2008 Nov-Dec;18(6):955-9. doi: 10.1177/112067210801800616.
引用本文的文献
1
The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization.不同抗血管内皮生长因子药物及预后生物标志物在监测近视脉络膜新生血管治疗中的疗效。
Int Ophthalmol. 2022 Sep;42(9):2729-2740. doi: 10.1007/s10792-022-02261-1. Epub 2022 Mar 31.
2
A systematic review of clinical practice guidelines for myopic macular degeneration.近视性黄斑变性的临床实践指南系统评价。
J Glob Health. 2022 Mar 26;12:04026. doi: 10.7189/jogh.12.04026. eCollection 2022.
3
Myopic choroidal neovascularisation: current concepts and update on clinical management.近视性脉络膜新生血管：当前概念及临床管理的最新进展
Br J Ophthalmol. 2015 Mar;99(3):289-96. doi: 10.1136/bjophthalmol-2014-305131. Epub 2014 Jul 1.
4
Reply to: Effect of axial length on myopic choroidal neovascularization.回复：眼轴长度对近视性脉络膜新生血管的影响
Graefes Arch Clin Exp Ophthalmol. 2013 Sep;251(9):2271. doi: 10.1007/s00417-012-2251-x. Epub 2013 Jan 5.
5
Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization.抗 VEGF 药物玻璃体腔内注射治疗近视性脉络膜新生血管的长期疗效及对脉络膜视网膜萎缩进展的影响。
Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):1-7. doi: 10.1007/s00417-012-2022-8. Epub 2012 Apr 19.
6
Predictive factors for visual outcome to intravitreal bevacizumab in young Chinese patients with myopic choroidal neovascularization.预测接受玻璃体内注射贝伐单抗治疗的年轻近视性脉络膜新生血管患者的视力预后的因素。
Retina. 2011 Oct;31(9):1835-40. doi: 10.1097/IAE.0b013e31821ba2dc.
7
Intravitreal bevacizumab versus photodynamic therapy for myopic choroidal neovascularization in a North-African population.玻璃体内贝伐单抗与光动力疗法治疗北非人群近视性脉络膜新生血管。
Graefes Arch Clin Exp Ophthalmol. 2011 Sep;249(9):1287-93. doi: 10.1007/s00417-011-1654-4. Epub 2011 Apr 12.
8
Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses.玻璃体内注射贝伐单抗治疗近视性脉络膜新生血管：两种不同初始剂量的比较。
Graefes Arch Clin Exp Ophthalmol. 2011 Apr;249(4):595-9. doi: 10.1007/s00417-010-1599-z. Epub 2011 Jan 14.
9
Low-fluence-rate photodynamic therapy to treat subfoveal choroidal neovascularization in pathological myopia. A study of efficacy and safety.低能量光动力疗法治疗病理性近视脉络膜新生血管。疗效与安全性研究。
Graefes Arch Clin Exp Ophthalmol. 2010 Apr;248(4):497-502. doi: 10.1007/s00417-009-1232-1.
10
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.光动力疗法联合玻璃体内注射曲安奈德治疗病理性近视继发脉络膜新生血管：一项前瞻性研究。
Br J Ophthalmol. 2007 Feb;91(2):131-3. doi: 10.1136/bjo.2006.106526.
本文引用的文献
1
Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes.高度近视眼中近黄斑区脉络膜新生血管氩绿激光光凝术后的长期视力
Eur J Ophthalmol. 2002 Mar-Apr;12(2):117-22. doi: 10.1177/112067210201200207.
2
Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups.高度近视脉络膜新生血管的长期视觉预后：年龄组间比较
Ophthalmology. 2002 Apr;109(4):712-9. doi: 10.1016/s0161-6420(01)01007-7.
3
Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients.高度近视患者黄斑下脉络膜新生血管的手术切除
Br J Ophthalmol. 2001 Sep;85(9):1041-3. doi: 10.1136/bjo.85.9.1041.
4
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.维替泊芬光动力疗法治疗病理性近视性黄斑下脉络膜新生血管。一项随机临床试验的1年结果——VIP报告第1号
Ophthalmology. 2001 May;108(5):841-52. doi: 10.1016/s0161-6420(01)00544-9.
5
Visual function after foveal translocation with 360-degree retinotomy and simultaneous torsional muscle surgery in patients with myopic neovascular maculopathy.近视性新生血管性黄斑病变患者行360度视网膜切开术及同时进行扭转肌手术的黄斑转位术后的视觉功能
Am J Ophthalmol. 2001 Jan;131(1):101-10. doi: 10.1016/s0002-9394(00)00770-4.
6
Radiotherapy for subfoveal neovascularisation associated with pathological myopia: a pilot study.病理性近视相关的黄斑中心凹下新生血管的放射治疗：一项试点研究。
Br J Ophthalmol. 2000 Jul;84(7):761-6. doi: 10.1136/bjo.84.7.761.
7
Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization.50岁及以上高度近视且未经治疗的脉络膜新生血管患者的视力结果。
Ophthalmology. 1999 Nov;106(11):2063-7. doi: 10.1016/S0161-6420(99)90484-0.
8
Macular translocation for surgical management of subfoveal choroidal neovascularizations in patients with AMD: first results.黄斑转位术治疗年龄相关性黄斑变性患者黄斑下脉络膜新生血管的手术管理：初步结果
Graefes Arch Clin Exp Ophthalmol. 1999 Jan;237(1):51-7. doi: 10.1007/s004170050194.
9
Anatomic and functional recovery of the fovea after foveal translocation surgery without large retinotomy and simultaneous excision of a neovascular membrane.
Am J Ophthalmol. 1998 Dec;126(6):839-42. doi: 10.1016/s0002-9394(98)00201-3.
10
Visual function after foveal translocation with scleral shortening in patients with myopic neovascular maculopathy.近视性新生血管性黄斑病变患者行黄斑转位联合巩膜缩短术后的视觉功能
Am J Ophthalmol. 1998 May;125(5):647-56. doi: 10.1016/s0002-9394(98)00021-x.
Zotero 插件